Human NKT cells direct the differentiation of myeloid APCs that regulate T cell responses via expression of programmed cell death ligands

Journal of Autoimmunity

Volumn 37, Issue 1, 2011, Pages 28-38

  Hegde, Subramanya ^a   Lockridge, Jennifer L ^a   Becker, Yusof A ^a   Ma, Shidong ^a   Kenney, Shannon C ^a   Gumperz, Jenny E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

ATP; Dendritic cells; NKT cells; PDL 1; PDL 2; Purinergic signalling; Regulatory myeloid APCs

Indexed keywords

PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2;

ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CONJUGATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER; MONOCYTE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD80; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; MYELOID CELLS; NATURAL KILLER T-CELLS; PHENOTYPE; T-LYMPHOCYTES;

EID: 79958046086     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.03.001     Document Type: Article

References (36)

1. Exley M., Garcia J., Wilson S.B., Spada F., Gerdes D., Tahir S.M.A., et al. CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology 2000, 100:37-47.
2. Spada F.M., Borriello F., Sugita M., Watts G.F., Koezuka Y., Porcelli S.A. Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. Eur J Immunol 2000, 30:3468-3477.
3. Kawano T., Cui J., Koezuka Y., Toura I., Kaneko Y., Motoki K., et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997, 278:1626-1629.
4. Kinjo Y., Tupin E., Wu D., Fujio M., Garcia-Navarro R., Benhnia M.R., et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 2006, 7:978-986.
5. Kinjo Y., Wu D., Kim G., Xing G.W., Poles M.A., Ho D.D., et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 2005, 434:520-525.
6. Mattner J., Debord K.L., Ismail N., Goff R.D., Cantu C., Zhou D., et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005, 434:525-529.
7. Fox L.M., Cox D.G., Lockridge J.L., Wang X., Chen X., Scharf L., et al. Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol 2009, 7:e1000228.
8. Park S.H., Benlagha K., Lee D., Balish E., Bendelac A. Unaltered phenotype, tissue distribution and function of Valpha14(+) NKT cells in germ-free mice. Eur J Immunol 2000, 30:620-625.
9. Wu L., Van Kaer L. Natural killer T cells and autoimmune disease. Curr Mol Med 2009, 9:4-14.
10. Falcone M., Facciotti F., Ghidoli N., Monti P., Olivieri S., Zaccagnino L., et al. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice. J Immunol 2004, 172:5908-5916.
11. Hammond K.J., Poulton L.D., Palmisano L.J., Silveira P.A., Godfrey D.I., Baxter A.G. Alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 1998, 187:1047-1056.
12. Lehuen A., Lantz O., Beaudoin L., Laloux V., Carnaud C., Bendelac A., et al. Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes. J Exp Med 1998, 188:1831-1839.
13. Hegde S., Fox L., Wang X., Gumperz J.E. Autoreactive natural killer T cells: promoting immune protection and immune tolerance through varied interactions with myeloid antigen-presenting cells. Immunology 2010, 130:471-483.
14. Sumida T., Sakamoto A., Murata H., Makino Y., Takahashi H., Yoshida S., et al. Selective reduction of T cells bearing invariant Va24JaQ antigen receptor in patients with systemic sclerosis. J Exp Med 1995, 182:1163-1168.
15. van der Vliet H.J., von Blomberg B.M., Nishi N., Reijm M., Voskuyl A.E., van Bodegraven A.A., et al. Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol 2001, 100:144-148.
16. Wilson S.B., Kent S.C., Horton H.F., Hill A.A., Bollyky P.L., Hafler D.A., et al. Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes. Proc Natl Acad Sci U S A 2000, 97:7411-7416.
17. Gausling R., Trollmo C., Hafler D.A. Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patients with relapsing-remitting multiple sclerosis. Clin Immunol 2001, 98:11-17.
18. Hegde S., Chen X., Keaton J.M., Reddington F., Besra G.S., Gumperz J.E. NKT cells direct monocytes into a DC differentiation pathway. J Leukoc Biol 2007, 81:1224-1235.
19. Hegde S., Jankowska-Gan E., Roenneburg D.A., Torrealba J., Burlingham W.J., Gumperz J.E. Human NKT cells promote monocyte differentiation into suppressive myeloid antigen-presenting cells. J Leukoc Biol 2009, 86:757-768.
20. Kaufmann A., Musset B., Limberg S.H., Renigunta V., Sus R., Dalpke A.H., et al. " Host tissue damage" signal ATP promotes non-directional migration and negatively regulates toll-like receptor signaling in human monocytes. J Biol Chem 2005, 280:32459-32467.
21. Ikehara Y., Yasunami Y., Kodama S., Maki T., Nakano M., Nakayama T., et al. CD4(+) Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J Clin Invest 2000, 105:1761-1767.
22. Seino K.I., Fukao K., Muramoto K., Yanagisawa K., Takada Y., Kakuta S., et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci U S A 2001, 98:2577-2581.
23. Sonoda K.H., Taniguchi M., Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol 2002, 168:2028-2034.
24. Oh K., Kim S., Park S.H., Gu H., Roopenian D., Chung D.H., et al. Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity. J Immunol 2005, 174:2030-2036.
25. Yang S.H., Jin J.Z., Lee S.H., Park H., Kim C.H., Lee D.S., et al. Role of NKT cells in allogeneic islet graft survival. Clin Immunol 2007, 124:258-266.
26. Faunce D.E., Gamelli R.L., Choudhry M.A., Kovacs E.J. A role for CD1d-restricted NKT cells in injury-associated T cell suppression. J Leukoc Biol 2003, 73:747-755.
27. Palmer J.L., Tulley J.M., Kovacs E.J., Gamelli R.L., Taniguchi M., Faunce D.E. Injury-induced suppression of effector T cell immunity requires CD1d-positive APCs and CD1d-restricted NKT cells. J Immunol 2006, 177:92-99.
28. Tulley J.M., Palmer J.L., Gamelli R.L., Faunce D.E. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide. Shock 2008, 29:269-277.
29. Kim H.J., Hwang S.J., Kim B.K., Jung K.C., Chung D.H. NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells. Immunology 2006, 118:101-111.
30. Sonoda K.H., Exley M., Snapper S., Balk S.P., Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J Exp Med 1999, 190:1215-1226.
31. Amarnath S., Costanzo C.M., Mariotti J., Ullman J.L., Telford W.G., Kapoor V., et al. Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. PLoS Biol 2010, 8:e1000302.
32. Netea M.G., Nold-Petry C.A., Nold M.F., Joosten L.A., Opitz B., van der Meer J.H., et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 2009, 113:2324-2335.
33. Piccini A., Carta S., Tassi S., Lasiglie D., Fossati G., Rubartelli A. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci U S A 2008, 105:8067-8072.
34. 7 receptors. FASEB J 2009, 23:1685-1693.
35. Khakh B.S., North R.A. P2X receptors as cell-surface ATP sensors in health and disease. Nature 2006, 442:527-532.
36. Abbracchio M.P., Burnstock G., Boeynaems J.M., Barnard E.A., Boyer J.L., Kennedy C., et al. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006, 58:281-341.